Linked deficiencies in extracellular PPi and osteopontin mediate pathologic calcification associated with defective PC-1 and ANK expression

被引:158
作者
Johnson, K
Goding, J
Van Etten, D
Sali, A
Hu, SI
Farley, D
Krug, H
Hessle, L
Millán, JL
Terkeltaub, R
机构
[1] Univ Calif San Diego, Vet Affairs Med Ctr, La Jolla, CA 92093 USA
[2] Monash Univ, Sch Med, Prahran, Vic, Australia
[3] Univ Minnesota, Sch Med, Vet Affairs Med Ctr, Minneapolis, MN 55455 USA
[4] Novartis Pharmaceut, Summit, NJ USA
[5] Burnham Inst, La Jolla, CA 92037 USA
关键词
ANK; hyperostosis; progressive ankylosis; ttw/ttw mouse;
D O I
10.1359/jbmr.2003.18.6.994
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Osteopontin and PPi both suppress hydroxyapatite deposition. Extracellular PPi deficiency causes spontaneous hypercalcification, yet unchallenged osteopontin knockout mice have only subtle mineralization abnormalities. We report that extracellular PPi deficiency promotes osteopontin deficiency and correction of osteopontin deficiency prevents hypercalcification, suggesting synergistic inhibition of hydroxyapatite deposition. Nucleotide pyrophosphatase phosphodiesterase (NPP) isozymes including PC-1 (NPPI) function partly to generate PPI, a physiologic calcification inhibitor. PPi transport is modulated by the membrane channel protein ANK. Spontaneous articular cartilage calcification, increased vertebral cortical bone formation, and peripheral joint and intervertebral ossific ankylosis are associated with both PC-1 deficiency and expression of truncated ANK in anklank mice. To assess how PC-1, ANK, and PPi regulate both calcification and cell differentiation, we studied cultured PC-1(-/-) and anklank mouse calvarial osteoblasts. PC-1(-/-) osteoblasts demonstrated similar to50% depressed NPP activity and markedly lowered extracellular PPi associated with hypercalcification. These abnormalities were rescued by transfection of PC-1 but not of the NPP isozyme B10/NPP3. PC-1(-/-) and anklank cultured osteoblasts demonstrated not only comparable extracellular PPi depression and hypercalcification but also marked reduction in expression of osteopontin (OPN), another direct calcification inhibitor. Soluble PC-1 (which corrected extracellular PPi and OPN), and OPN itself (greater than or equal to15 pg/ml), corrected hypercalcification by PC-1(-/-) and anklank osteoblasts. Thus, linked regulatory effects on extracellular PPi and OPN expression mediate the ability of PC-1 and ANK to regulate calcification.
引用
收藏
页码:994 / 1004
页数:11
相关论文
共 48 条
[1]  
Baba H, 1997, EUR J HISTOCHEM, V41, P191
[2]   Quantification of osteopontin in human plasma with an ELISA: Basal levels in pre- and postmenopausal women [J].
Bautista, DS ;
Saad, Z ;
Chambers, AF ;
Tonkin, KS ;
OMalley, FP ;
Singhal, H ;
Tokmakejian, S ;
Bramwell, V ;
Harris, JF .
CLINICAL BIOCHEMISTRY, 1996, 29 (03) :231-239
[3]   Phosphate is a specific signal for induction of osteopontin gene expression [J].
Beck, GR ;
Zerler, B ;
Moran, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (15) :8352-8357
[4]   Osteopontin deficiency increases mineral content and mineral crystallinity in mouse bone [J].
Boskey, AL ;
Spevak, L ;
Paschalis, E ;
Doty, SB ;
McKee, MD .
CALCIFIED TISSUE INTERNATIONAL, 2002, 71 (02) :145-154
[5]   Matrix GLA protein modulates differentiation induced by done morphogenetic protein-2 in C3H10T1/2 cells [J].
Bostrom, K ;
Tsao, D ;
Shen, S ;
Wang, Y ;
Demer, LL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (17) :14044-14052
[6]   Phosphocitrate as a potential therapeutic strategy for crystal deposition disease. [J].
Cheung H.S. .
Current Rheumatology Reports, 2001, 3 (1) :24-28
[7]  
CRAIG AM, 1989, J BIOL CHEM, V264, P9682
[8]   Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation [J].
Ducy, P ;
Zhang, R ;
Geoffroy, V ;
Ridall, AL ;
Karsenty, G .
CELL, 1997, 89 (05) :747-754
[9]  
Furusawa N, 1996, EUR J HISTOCHEM, V40, P199
[10]   Ecto-phosphodiesterase/pyrophosphatase of lymphocytes and non-lymphoid cells: structure and function of the PC-1 family [J].
Goding, JW ;
Terkeltaub, R ;
Maurice, M ;
Deterre, P ;
Sali, A ;
Belli, SI .
IMMUNOLOGICAL REVIEWS, 1998, 161 :11-26